Work

A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101

Year: 2021

Type: article

Study design: Clinical Trial

Source: Oral Oncology

DOI: 10.1016/j.oraloncology.2020.105171

Authors: Michael J. Jelinek, Nathan R. Foster, Alex J. Zoroufy, Gary K. Schwartz, Pamela N. Munster, Tanguy Y. Seiwert, Jonas A. de Souza, Everett E. Vokes

Institutions: Rush University Medical Center, University of Chicago, University of Chicago Medical Center, Mayo Clinic, Herbert Irving Comprehensive Cancer Center, Columbia University, University of California, San Francisco, University of California San Francisco Medical Center, UCSF Helen Diller Family Comprehensive Cancer Center, University of Chicago Medicine Comprehensive Cancer Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: AbbVie, National Institutes of Health, National Cancer Institute

Awards: Alliance Statistics and Data Management Center, G3053988604, G4185274752, G4340946455, UG1 - NCTN (Network Lead), UNC Lead Academic Participating Site, Alliance for Clinical Trials in Oncology Operations Center

OpenAlex ID: W3121908754

FWCI: 2.899

Cites: 38

Cited by: 19

Related to: 10